Mikhail Blagosklonny: The man who’s passionate about keeping you alive.

Aging and Cancer are one of the biggest killers in our world. Aging definitely is expected to be the end of everyone. According to scientists, aging causes age-related diseases which eventually terminates a life. And research has actually shown that majority of people die from age-related diseases. However, there’s a passionate professor, on this subject, that doesn’t believe it has to be that way. He believes by slowing aging through some particular drugs can delay age-related diseases including cancer.The professor is Mikhail Blagosklonny, a professor of Oncology at the Roswell Park Cancer Institute and the editor-in-chief of Oncotarget. Basically, this professor studies Aging and Cancer. His tertiary education began at the First Pavlov State Medical University of St. Petersburg. He bagged an MD in Internal Medicine and later earned a Ph.D. in Experimental Medicine and Cardiology from the same university. This brilliant scientist specializes in the research areas of cellular and molecular biology and clinical investigations. His primary research interests are Bio gerontology, anti-aging drugs, cancer, and targeted cancer therapies that shield healthy cells in the body against getting damaged. He has written more than 300 research articles, book chapters, and journal reviews; they are all published in his name.

Professor Mikhail Blagosklonny has been researching on the possibility of controlling aging and cancer. He proposed and argued for the use of Rapamycin. For non-scientist, this drug is a non-toxic, well-tolerated drug that is suitable for daily oral administration used in the treatment of cancer. What Mikhail argues is that this drug can be suitable for extending our life on earth. This argument is based on the hyperfunction theory that describes aging as a continuation of growth, driven by signaling pathways such as TOR (Target of Rapamycin). The TOR-centric model predicts that Rapamycin can be used in humans to treat aging and prevent diseases. This hyperfunction theory definition of aging is radically different from the well accepted old definition that has mainly limited the research of anti-aging drugs in the past.As the anti-aging drug began development, it was considered by other scientists in the field to be an utopic project and that it would never be possible to negate the effects of aging.

  1. Mikhail Blagosklonny, however, showed the world that it was actually possible using the TOR-centric model, and today his research has been quoted by many oncology newsletters around the world as the next-gen discovery that will change how medicine shapes out, as diseases like cancer, that derive from aging, won’t be nearly as common anymore.

The astounding researches by the professor weren’t taking seriously within and outside the science circles before now, but it has started to change. More people are paying attention and recognizing his works and the great contributions he has already made to the advancement of the human race. Majority of his works on anti-aging drugs are making major newspaper headlines today all over the world. His commitment, persistence, and love for humanity have made him become one of the most acclaimed oncology researchers in the world.

Recent Comments

    Hi, guest!